These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9041654)

  • 21. Effects on ligand interaction and membrane translocation of the positively charged arginine residues situated along the C1 domain binding cleft in the atypical protein kinase C isoforms.
    Pu Y; Peach ML; Garfield SH; Wincovitch S; Marquez VE; Blumberg PM
    J Biol Chem; 2006 Nov; 281(44):33773-88. PubMed ID: 16950780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1.
    Lorenzo PS; Bögi K; Hughes KM; Beheshti M; Bhattacharyya D; Garfield SH; Pettit GR; Blumberg PM
    Cancer Res; 1999 Dec; 59(24):6137-44. PubMed ID: 10626804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phorbol ester and hydrogen peroxide synergistically induce the interaction of diacylglycerol kinase gamma with the Src homology 2 and C1 domains of beta2-chimaerin.
    Yasuda S; Kai M; Imai S; Kanoh H; Sakane F
    Biochem J; 2008 Jan; 409(1):95-106. PubMed ID: 17803461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The solution structure of C1-T1, a two-domain proteinase inhibitor derived from a circular precursor protein from Nicotiana alata.
    Schirra HJ; Scanlon MJ; Lee MC; Anderson MA; Craik DJ
    J Mol Biol; 2001 Feb; 306(1):69-79. PubMed ID: 11178894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interplay of C1 and C2 domains of protein kinase C-alpha in its membrane binding and activation.
    Medkova M; Cho W
    J Biol Chem; 1999 Jul; 274(28):19852-61. PubMed ID: 10391930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diacylglycerol-induced membrane targeting and activation of protein kinase Cepsilon: mechanistic differences between protein kinases Cdelta and Cepsilon.
    Stahelin RV; Digman MA; Medkova M; Ananthanarayanan B; Melowic HR; Rafter JD; Cho W
    J Biol Chem; 2005 May; 280(20):19784-93. PubMed ID: 15769752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the interaction of phorbol esters with the C1 domain of MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase) alpha/beta.
    Choi SH; Czifra G; Kedei N; Lewin NE; Lazar J; Pu Y; Marquez VE; Blumberg PM
    J Biol Chem; 2008 Apr; 283(16):10543-9. PubMed ID: 18263588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes.
    Irie K; Nakagawa Y; Ohigashi H
    Curr Pharm Des; 2004; 10(12):1371-85. PubMed ID: 15134488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A PKR-like eukaryotic initiation factor 2alpha kinase from zebrafish contains Z-DNA binding domains instead of dsRNA binding domains.
    Rothenburg S; Deigendesch N; Dittmar K; Koch-Nolte F; Haag F; Lowenhaupt K; Rich A
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1602-7. PubMed ID: 15659550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural determinants of phorbol ester binding activity of the C1a and C1b domains of protein kinase C theta.
    Czikora A; Pany S; You Y; Saini AS; Lewin NE; Mitchell GA; Abramovitz A; Kedei N; Blumberg PM; Das J
    Biochim Biophys Acta Biomembr; 2018 May; 1860(5):1046-1056. PubMed ID: 29317197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/pi interaction.
    Sugimoto T; Itagaki K; Irie K
    Bioorg Med Chem; 2008 Jan; 16(2):650-7. PubMed ID: 17977729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid-phase synthesis, mass spectrometric analysis of the zinc-folding, and phorbol ester-binding studies of the 116-mer peptide containing the tandem cysteine-rich C1 domains of protein kinase C gamma.
    Fukuda H; Irie K; Nakahara A; Ohigashi H; Wender PA
    Bioorg Med Chem; 1999 Jun; 7(6):1213-21. PubMed ID: 10428394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conserved domains subserve novel mechanisms and functions in DKF-1, a Caenorhabditis elegans protein kinase D.
    Feng H; Ren M; Rubin CS
    J Biol Chem; 2006 Jun; 281(26):17815-26. PubMed ID: 16613842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of conserved amino acids N-terminal of the PKC epsilon C1b domain crucial for protein kinase C epsilon-mediated induction of neurite outgrowth.
    Ling M; Trollér U; Zeidman R; Stensman H; Schultz A; Larsson C
    J Biol Chem; 2005 May; 280(18):17910-9. PubMed ID: 15718244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diacylglycerol lactones targeting the structural features that distinguish the atypical C1 domains of protein kinase C ζ and ι from typical C1 domains.
    Pu Y; Kang JH; Sigano DM; Peach ML; Lewin NE; Marquez VE; Blumberg PM
    J Med Chem; 2014 May; 57(9):3835-44. PubMed ID: 24684293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p23/Tmp21 differentially targets the Rac-GAP beta2-chimaerin and protein kinase C via their C1 domains.
    Wang H; Kazanietz MG
    Mol Biol Cell; 2010 Apr; 21(8):1398-408. PubMed ID: 20164256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis for failure of "atypical" C1 domain of Vav1 to bind diacylglycerol/phorbol ester.
    Geczy T; Peach ML; El Kazzouli S; Sigano DM; Kang JH; Valle CJ; Selezneva J; Woo W; Kedei N; Lewin NE; Garfield SH; Lim L; Mannan P; Marquez VE; Blumberg PM
    J Biol Chem; 2012 Apr; 287(16):13137-58. PubMed ID: 22351766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The C1 domain of Vav3, a novel potential therapeutic target.
    Kelsey JS; Géczy T; Kaler CJ; Blumberg PM
    Cell Signal; 2017 Dec; 40():133-142. PubMed ID: 28927664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation with drug cytotoxicity.
    Roaten JB; Kazanietz MG; Caloca MJ; Bertics PJ; Lothstein L; Parrill AL; Israel M; Sweatman TW
    Mol Cancer Ther; 2002 May; 1(7):483-92. PubMed ID: 12479266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of an amino acid residue in the protein kinase C C1b domain crucial for its localization to the Golgi network.
    Schultz A; Ling M; Larsson C
    J Biol Chem; 2004 Jul; 279(30):31750-60. PubMed ID: 15145947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.